There has been an increased detection of incidental pancreatic cystic neoplasms (PCNs) over recent years. 
INTRODUCTION
There has been an increase in the detection of pancreatic cystic neoplasms (PCNs) over recent years. The rising prevalence, which has been estimated to range from 3 to 14% (1, 2) , can be in part attributed to the increased availability and utilization of Conversely, the diagnostic accuracy of EUS for nodules is limited and was estimated to be 57% in a pathology-based study of IPMNs 
Cyst Fluid Evaluation
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Molecular Analysis
There has been an increasing effort over recent years to identify molecular biomarkers that may assist in the evaluation of PCNs.
Recently, a study of 142 surgically resected pancreas cysts revealed that KRAS mutation was 54% sensitive and 100% specific for mucinous cysts (22) . The authors demonstrated that a combination of CEA and KRAS was associated with an improved sensitivity of 83% for mucinous lesions with a decrease in specificity to 85%. Mutation in GNAS has been another diagnostic marker that has been studied for the evaluation of PCNs. 
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